21.8 C
New York
Wednesday, June 10, 2026

Tag: development

Think Together Recognizes Jesse Durkin and Ricardo Molina with the 2026 Randy Barth Leadership Award

Peer-nominated award honors leaders who exemplify community impact and a commitment to changing the odds for kids across California.SANTA ANA, Calif., June 9, 2026...

Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China

SHANGHAI and HONG KONG, June 10, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to...

Polymatech Establishes Asia-Pacific Advanced Manufacturing Hub In Singapore

One of Singapore's first dedicated commercial-scale LED Chip-on-Board (CoB) packaging facilities — anchoring a vertically integrated global semiconductor and advanced electronics supply chain spanning...

Parabilis Medicines Announces Pricing of Upsized Initial Public Offering

CAMBRIDGE, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet historically undruggable, protein targets driving human disease, today announced the pricing of its upsized initial public offering of 33,500,000 shares of its common stock at a price to the public of $20.00 per share. In addition, Parabilis has granted the underwriters a 30-day option to buy an additional 5,025,000 shares of its common stock at the initial public offering price, less underwriting discounts and commissions.

QBit Semiconductor Announces Acquisition of 60% Stake in Singapore’s SinChip

Enhancing ASIC Design Services Layout, Expanding Global Footprint and Growth PerformanceTAIPEI, June 10, 2026 /PRNewswire/ -- QBit Semiconductor (TWSE: 7913; hereinafter referred to as...

Lynk Pharmaceuticals’ Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor

HANGZHOU, China, SHANGHAI and BOSTON, June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on...

ARCPOINT ANNOUNCES APPOINTMENT OF PETER KENDALL AS INTERIM CHIEF EXECUTIVE OFFICER

GREENVILLE, South Carolina, June 09, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces that its Board of Directors has appointed Peter Kendall as Interim Chief Executive Officer of the Company, effective June 9, 2026. Mr. Kendall’s appointment remains subject to acceptance by the TSX Venture Exchange (the “TSXV” or the “Exchange”), including acceptance of the Exchange’s required Personal Information Form and completion of customary Exchange review and verification procedures.

FDA approves Lilly’s EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

EBGLYSS is now the only approved option that offers as few as six maintenance injections per year with no required topicals from the startINDIANAPOLIS,...

Hut 8 Closes $4.25 Billion of Investment-Grade Senior Secured Notes for Beacon Point Data Center Project

Hut 8's second investment-grade data center construction bond — fully amortizing, non-recourse, and non-dilutive — rated Baa2 and priced 20 basis points inside the...

RMG ML Sports Holdings Announces the Pricing of $200 Million Initial Public Offering

Incline Village, NV, June 09, 2026 (GLOBE NEWSWIRE) -- RMG ML Sports Holdings (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by Chief Executive Officer, James Carpenter, and President and Chief Financial Officer, Douglas Horlick, today announced the pricing of its initial public offering of 20,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right to receive one-eighth (1/8) of one Class A ordinary share upon the consummation of the Company’s initial business combination. The units are expected to trade on the Global Market tier of the Nasdaq Stock Market (“Nasdaq”) under the ticker symbol “SHOTU” beginning June 10, 2026. Once the securities comprising the units begin separate trading, the ordinary shares and the rights are expected to be traded on Nasdaq under the symbols “SHOT” and “SHOTR,” respectively.

Maui Land & Pineapple Company, Inc. Appoints a Chief Investment Officer

KAPALUA, Hawai‘i, June 09, 2026 (GLOBE NEWSWIRE) -- Maui Land & Pineapple Company, Inc. (NYSE: MLP) today announced the appointment of Ryan Panopio as the Company’s Chief Investment Officer effective June 3, 2026.

Ramaco Resources to Participate in StoneX Fourth Annual Natural Resources Summit

LEXINGTON, Ky., June 9, 2026 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB) ("Ramaco" or the "Company") today announced that Jeremy Sussman, Chief Financial...

The Inner Circle acknowledges Dr. Susan Blyskal as a Pinnacle Professional Member Inner Circle of Excellence

MYRTLE BEACH, S.C., June 9, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Susan Blyskal is acknowledged as a Pinnacle Professional Member Inner Circle...

Peak Energy and General Motors Partner to Scale Next-Generation Energy Storage Technology for the Grid

Partnership combines Peak Energy's market leading passively cooled energy storage platform with GM's battery expertise to scale next-generation sodium-ion batteries for grid-scale storageBURLINGAME, Calif.,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment